Heart attacks are not caused by COVID-19 vaccine, avoid unnecessary fear: Minister
He was addressing media persons after inaugurating a free heart check-up camp for journalists in Kalaburagi organised by the district unit of Karnataka Union of Working Journalists (KUWJ) in association with Sri Jayadeva Institute of Cardiovascular Sciences and Research (SJICSR) here on Wednesday.
Dr. Patil reiterated that a study by the Indian Council of Medical Research has confirmed that there is no link between increasing sudden deaths in young adults with the vaccine. Even the expert committee set up by the State government to study the exact cause of increasing cardiac-related deaths has found no link with vaccination.
Dr. Patil suggested that journalists, due to the high-stress nature of their profession, should prioritize regular cardiac check-ups. He also advised journalists to adopt a healthy lifestyle by following a balanced diet, regular exercise and mindfulness practices like yoga and meditation, while avoiding tobacco, smoking and excessive alcohol consumption.
Cardiologist in the Kalaburagi branch of Jayadeva Hospital Veeresh Patil Hebbal said that maintaining a healthy heart is crucial for the overall well-being of individual and longevity. He clarified that not all heart-related chest pain is due to blockages in the arteries.
KUWJ district president Baburao Yadrami thanked the Minister for taking the initiative to organise a cardiac check-up camp for journalists.
Nearly 600 media persons including office staff of both print and electronic media, are expected to benefit from the camp at Jayadeva Hospital.
The camp will be conducted on Saturdays and Sundays for the next six weeks with 50 OPD slots every day.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
13 minutes ago
- The Hindu
COVID-19's hidden toll: how the pandemic has aged our brains
The COVID-19 pandemic left its mark on our bodies in ways we are only now beginning to understand. Beyond the familiar symptoms of fever and cough, scientists have discovered something deeply concerning: the virus and the stress of the pandemic are literally ageing our brains faster than normal. The research shows that COVID-19 doesn't just affect our lungs—it attacks our brain health, potentially adding months or even years to our biological brain age. This discovery has profound implications for millions of people worldwide, especially as we learn more about long COVID or Post-Acute Sequalae of COVID-19 (PASC) and its lasting effects. What we are learning about brain ageing Think of your brain like a car. Just as a car accumulates wear and tear over time, our brains naturally age as we get older. Scientists can now measure this process using advanced brain scans to determine someone's 'brain age'—how old the brain appears compared to the person's actual age. In healthy people, brain age typically matches chronological age fairly closely. But recent studies have found something alarming: people exposed to COVID-19 or even just the pandemic environment show brains that appear significantly older than expected. A major study using brain scan data from over 15,000 healthy adults found that people exposed to the pandemic environment showed an average brain age increase of 5.5 months compared to those studied before the pandemic. Even more concerning, this acceleration was more pronounced in men and those from disadvantaged socioeconomic backgrounds. The double whammy: virus plus stress COVID-19 appears to age brains through two main pathways. First, the virus itself is neurotropic—meaning it can invade and directly damage brain tissue. Studies show that SARS-CoV-2 has been found in neural tissues up to 230 days after infection, and immune system activation has persisted for as long as 2.5 years. Second, the psychological stress and social isolation of the pandemic created a perfect storm for brain health. Researchers found that when people were shown faces labelled as 'infected,' their brains responded with elevated activity in fear and stress regions, including areas critical for memory and emotion. This suggests that fear of the virus alone can alter how our brains function. Perhaps nowhere is this brain aging more apparent than in long COVID patients. Studies tracking COVID survivors for three years found that among those who weren't hospitalised, the brain still showed signs of ongoing damage, with cognitive issues persisting years after infection. Long COVID affects at least 10% of people recovering from COVID-19 infections and possibly up to 50-70% of those who were hospitalised. Hallmark symptoms include brain fog, memory problems, difficulty concentrating, and persistent fatigue—all signs that the brain is struggling to function normally. Brain scans of COVID survivors have shown measurable drops in cognitive abilities, with statistical significance, suggesting real physical changes in brain structure and function. Particularly troubling is evidence that young people haven't escaped this brain ageing effect. Studies of adolescents before and after pandemic shutdowns found significantly higher levels of anxiety and depression, along with brain scans showing signs of accelerated brain maturation equivalent to 5-6 months beyond their actual age. These effects varied by gender, with teenage girls showing widespread brain changes across 30 regions, including areas crucial for social and emotional processing, corresponding to about 4.2 years of accelerated aging. These findings suggest that the social and educational disruptions of the pandemic may have lasting effects on developing brains. The science behind the damage How exactly does COVID-19 age our brains? The process involves several mechanisms working together: Inflammation: The virus triggers widespread inflammation throughout the body, including the brain. This chronic inflammation damages brain cells and disrupts normal brain function. Blood-Brain barrier breakdown: COVID-19 can damage the protective barrier that normally keeps harmful substances out of the brain, allowing inflammation and toxins to enter. Oxygen deprivation: Even mild COVID infections can reduce oxygen levels, starving brain cells of the fuel they need to function properly. Immune system confusion: The virus can cause the immune system to attack healthy brain tissue, similar to autoimmune diseases. What this means for recovery times The latest three-year studies show both good and concerning news. Among people who had mild COVID and weren't hospitalised, the increased risk of death disappeared after the first year, and most brain-related symptoms improved significantly over time. However, those who were hospitalised during their COVID infection, continued to show elevated death rates and persistent brain problems even three years later, with substantial ongoing health impacts. This suggests that the severity of the initial infection plays a crucial role in long-term brain health outcomes. The news however, isn't all doom and gloom. Innovative treatment approaches are showing promise in reversing some of these effects. At specialised clinics, patients with persistent long COVID symptoms have seen significant improvements using comprehensive treatment programmes that combine advanced neurotechnology with holistic therapies. Integrative neurorehabilitation, driven by neurotechnology and holistic therapies, can improve outcomes in individuals with Long COVID. Such interventions not only alleviate symptoms but may also slow or reverse the neurocognitive aging seen in this population. The road ahead As we continue to understand COVID-19's long-term effects, it is clear that brain health must be a priority in recovery efforts. With an estimated 65 million people worldwide living with long COVID symptoms, the scale of this challenge requires coordinated medical research and treatment approaches. The pandemic has taught us that infectious diseases can have effects far beyond their initial symptoms. By taking brain ageing seriously and developing comprehensive treatment approaches, we can help millions of people recover not just their physical health, but their cognitive abilities as well. Understanding these effects is the first step toward healing. With continued research and innovative treatments, there's reason for hope that we can help mitigate the neurological impacts of the pandemic and restore brain health through multidisciplinary and personalised care paradigms. (Dr. Rema Raghu is chief clinical officer, Buddhi Clinic, Chennai. drrema@ Vivek Misra is senior consultant , neuromodulation and clinical sciences, Buddhi Clinic; Thyagarajan S. is research assistant, Buddhi Clinic)
The Wire
2 hours ago
- The Wire
Individual Health Insurers Seek Largest Premium Hikes in Over Five Years
New Delhi [India], August 11: Indian consumers are witnessing significant changes in the individual health insurance and private medical insurance landscape. Over the last few months, many policyholders have reported steep rises in their health insurance premiums. According to official filings and market reports, individual health insurers are now seeking their largest premium hikes in over five years. This trend affects millions of families and individuals who rely on these products for financial security during medical emergencies. Factors leading to premium hikes Several reasons have led individual health insurers to revise rates. During the COVID-19 pandemic, insurance companies faced a sharp surge in claims related to hospitalisation and treatments under private medical insurance policies. In FY22-23, claims ratios for health insurers crossed 90%, up from averages of 60-70% in previous years. This means that for every Rs. 100 collected as premium, insurers paid Rs. 90 as claims, squeezing their profits. Rising medical costs are another key factor. According to the National Health Authority, medical inflation in India averaged 14% in 2022-23, one of the highest in Asia. Treatments, diagnostics, and even standard procedures in private hospitals have become expensive. Insurers adjust premiums upwards to keep pace with these higher payouts. India's Insurance Regulatory and Development Authority (IRDAI) reports that insurers have also enhanced coverage with new features such as coverage for mental health, modern treatments like robotic surgery, and day-care procedures. While these are valuable to policyholders, they increase claim outgo, adding pressure on premiums. Regulatory permission for premium increases Health insurers cannot increase premiums arbitrarily. They must file premium revision applications with the IRDAI, which closely examines the justification. In early 2024, at least 14 leading private and public sector insurers, including HDFC Ergo, ICICI Lombard, Star Health, and National Insurance, filed for hikes ranging from 15% to 35%, according to industry estimates and filings reviewed by Mint. For most individual health insurance and private medical insurance products, this is the sharpest rise since FY18, when premiums saw 10-14% increases. Major insurers argue that cumulative inflation and elevated claims from 2020 to 2023 require a correction in rates to maintain product viability. Which policies and consumers are affected the most Impact on individual health insurance policyholders The premium hikes have the greatest impact on individual health insurance customers. These are people who buy policies directly, rather than as part of an employer scheme or family floater. For example, a standard Rs. 5 lakh health cover from a leading private insurer, which was priced at Rs. 8,000 for a 30-year-old in 2019, will now cost between Rs. 10,000 and Rs. 11,000, after the approved hike. For senior citizens or those with pre-existing ailments, increases are even sharper, sometimes up to 25-30%. Group insurance plans see slower increases Corporates and organisations that buy group or employee policies have bargaining power and larger risk pools. Hence, while group policies also see some price increase, these are usually lower than those for individual retail buyers. However, experts warn that persistent medical inflation will eventually influence group premiums as well. How premium hikes affect affordability and healthcare access Increased out-of-pocket expenses With higher premiums, policyholders, especially from the middle class and self-employed segments, are forced to rethink medical cover. Some may reduce the sum insured, opt for policies with co-payment, or even drop coverage altogether. A study by the Insurance Brokers Association of India in early 2024 observed that up to 18% of individual health insurance policyholders considered downgrading or cancelling their policies following the hike announcements. Financial strain on families and vulnerable groups Health costs are among the largest unpredictable expenses for Indian families. A sudden increase in annual premiums by Rs. 2,000 to Rs. 5,000 can strain household budgets and lead to delayed renewals or lapses in cover. Senior citizens, who have higher medical needs, are particularly affected as they already pay the highest premiums in the market. This reduces access to private medical insurance, forcing dependence on limited and often overburdened public healthcare services. IRDAI's role and regulatory responses Ensuring consumer protection and industry viability The IRDAI is responsible for balancing the financial health of insurance companies with the well-being of policyholders. The regulator has sought detailed actuarial data and justifications for each premium increase. In numerous cases, IRDAI has moderated or staggered the hikes, asking insurers to spread out increases over two to three years to prevent sudden financial shock. Product standardisation and transparency IRDAI has also introduced guidelines to improve transparency in product features and pricing. Insurers must now clearly state the reason for premium increases in their policy renewal notices and offer comparison charts with other available products, helping consumers make informed decisions. To promote access, IRDAI encourages the launch of standardised products such as Arogya Sanjeevani and Saral Suraksha Bima, which provide basic cover at affordable rates. While these may not have all the bells and whistles of private medical insurance plans, they ensure minimum protection for a larger population base. Expert tips to manage rising individual health insurance costs Shop and compare policies every renewal cycle With premium hikes, loyalty to one insurer is no longer the best option. IRDAI's guidelines now allow portability, making it easy for consumers to switch between insurers while retaining continuity benefits. Always compare features and pricing on official platforms such as the IRDAI website or trusted aggregators before renewing your individual health insurance. Consider top-ups and super top-ups Instead of buying an expensive comprehensive plan, you can take a base cover and add a super top-up plan for higher coverage at a lower overall premium. For example, taking a Rs. 5 lakh base cover with a Rs. 20 lakh super top-up may cost less than buying a single Rs. 25 lakh policy. Many experts recommend this approach for middle-income families and self-employed professionals who need higher protection but want to keep annual outgo manageable. Opt for higher deductibles and co-payments If you are healthy and financially secure, choosing a higher deductible or voluntary co-pay option reduces your annual premium. However, this means you will pay a fixed amount from your pocket in the event of a claim. Carefully evaluate your risk appetite and medical history before choosing this route. Use wellness benefits and claim-free discounts Most individual health insurers now offer wellness programmes, discounts for claim-free years, or incentives for maintaining a healthy lifestyle. Actively use these features to reduce your premiums for private medical insurance. Simple steps like routine health check-ups, regular exercise, and non-smoking can have a tangible financial benefit. How to avoid policy lapses after premium hikes Plan for timely renewal Irrespective of premium increases, always renew your policy before the due date. Lapsed individual health insurance policies may result in a loss of waiting period benefits and continuity for pre-existing diseases. Many insurers offer a grace period of 15 to 30 days, but cover for claims is not available during lapses. Seek expert or a financial advisor help If you are unsure about the impact of premium hikes, consult a trusted insurance advisor or financial planner. They can analyse your current needs, suggest suitable individual health insurance products, and guide you on combining covers or switching options without losing protection. Conclusion: Proposed premium hikes in individual health insurance and private medical insurance represent the most substantial increases in over five years for Indian policyholders. While driven by rising healthcare costs, greater claim payouts, and market competition, they create affordability challenges for middle-class families and vulnerable groups. To navigate this evolving landscape, consumers should regularly compare policies, use top-ups creatively, and leverage IRDAI's consumer protection initiatives. Reviewing your health coverage priorities, seeking expert advice, and staying aware of regulatory updates will help manage the impact of premium increases without sacrificing protection. (Disclaimer: The above press release comes to you under an arrangement with PNN and PTI takes no editorial responsibility for the same.). PTI PWR
Hans India
2 hours ago
- Hans India
Study finds potential biomarker for long Covid
US researchers have identified a potential biomarker for long Covid that may help develop better diagnostics and potential treatments for the condition. Currently, clinicians confer a diagnosis of long Covid based upon a collection of symptoms that patients develop after SARS-CoV-2 infection. The study, reported in the journal Infection, details the detection of SARS-CoV-2 protein fragments within extracellular vesicles (EVs) -- tiny, naturally occurring packages that help cells share proteins, metabolites, and other materials. "If a patient arrives in clinic and they relate the persistence of typical signs and symptoms of long Covid, 12 weeks or more after Covid-19 infection, I give them a presumptive diagnosis, but I don't have any blood tests or biomarkers to confirm this diagnosis," said William Stringer, from the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Centre. The new biomarker could be the first specific and quantifiable indicator for confirming long Covid. The researchers collected and analysed blood samples from 14 patients over 12 weeks of aerobic exercise training (56 samples in all) in a clinical trial on long Covid. The team found 65 distinct protein fragments from SARS-CoV-2 inside the EVs. These fragments come from the virus's Pp1ab protein -- an RNA Replicase enzyme which is key to how the virus copies itself and makes other viral particles. This protein is found uniquely in SARS-CoV-2, and not in uninfected human cells, noted Asghar Abbasi, another researcher from Lundquist Institute. Significantly, the researchers found that these viral peptides were demonstrated in each subject, but not in each blood draw, in the EVs of long Covid patients and were not detected in a separate control group of pre-pandemic EV samples. Although the identified peptides originated from one of the virus's largest proteins, the researchers did not detect other comparably large proteins indicative of active viral replication. The peptides contained in the EVs may be just molecular "trash" left over after the formation of new viral proteins, they said. "We haven't run [our tests] on people without long Covid symptoms who are currently, or who were, infected with Covid," said Stringer. "This raises the question: is this just continuing to take out the trash from the Covid-infected cell, or is this really ongoing replication someplace? I think that's the mechanistic issue that needs to be resolved in future studies."
